NaviNet

About NaviNet

NaviNet operates as a healthcare collaboration network, providing a web-based platform designed to facilitate communication and data exchange between healthcare providers and health insurance plans. Originally founded as NaviMedix in 1997 by Tom Morrison and Jeremy Nobel, the company rebranded to NaviNet in April 2009. In January 2016, NaviNet was acquired by NantHealth, a cloud-based IT company focused on combining genomic science and big data to transform healthcare. The acquisition was a strategic move for NantHealth to integrate NaviNet's extensive network of providers and payers into its own clinical and operating systems.

The company's core business revolves around its multi-payer portal, NaviNet Open, which allows healthcare providers a single point of access to multiple health plans. This significantly streamlines administrative and clinical workflows. The platform is offered at no cost to providers, with revenue generated from the health plans that use the network to communicate with their provider partners. NaviNet serves a substantial client base that includes over 40 health plans, such as various Blue Cross Blue Shield payers, Aetna, and Cigna, and a network of over 450,000 healthcare professionals in more than 170,000 provider offices and 2,000 hospitals across the United States.

NaviNet's platform offers a comprehensive suite of services aimed at improving efficiency and reducing administrative costs for both payers and providers. Key features include real-time eligibility and benefits verification, claims status inquiries, prior authorization submissions, and secure document exchange. This allows providers to quickly access critical patient information, manage claims throughout their lifecycle, and communicate securely with insurance companies, replacing slower paper and phone-based transactions. Since the launch of NaviNet Open in 2014, its capabilities have expanded beyond basic administrative transactions to support clinical collaboration in areas like chronic disease management. Following its acquisition by NantHealth, the platform was envisioned to also serve as a portal for disseminating information about new clinical agents and providing access to cancer clinical trials.